Presentation The Structural Heart Disease Summit 2018 Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR Presenter: Howard C. Herrmann, Fabian Nietlispach, Hasan Ahmad, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Societal Impact of Access Restrictions to TAVR: Viewpoint From The Canadian Health Technology Assessment (HTA) Agency Presenter: Randolph P. Martin, Mark J. Russo, Harindra Wijeysundera June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Evolut R Low-Risk Presenter: Jeffrey J. Popma June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis Presenter: Howard C. Herrmann, Fabian Nietlispach, Futoshi Yamanaka, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Partner 3 Low-Risk Presenter: Martin B. Leon June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Improved Temporary Transvenous Pacemakers: The BioTrace Tempo Lead Presenter: Tamim Nazif, Steven J. Yakubov June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Cases of Unusual Mechanisms of Coronary Occlusion During TAVR Presenter: Omar Khalique June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation Presenter: Howard C. Herrmann, Fabian Nietlispach, Mohamad Lazkani, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Large Hole Transfemoral Closure III: The MANTA Device Presenter: Nicolas M. Van Mieghem June 21, 2018
Presentation The Structural Heart Disease Summit 2018 TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors? Presenter: Allan Schwartz, Stephan Windecker, Neil E. Moat June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes Presenter: Azeem Latib June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Large Hole Transfemoral Closure II: The InSeal Device Presenter: Ran Kornowski June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors Presenter: Howard C. Herrmann, Fabian Nietlispach, Roberto Spina, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Large Hole Transfemoral Closure I: The PerQseal Device Presenter: Jeffrey J. Popma June 21, 2018
Presentation The Structural Heart Disease Summit 2018 TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients Presenter: John C Laschinger, Mathew Williams, Jung-Min Ahn June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines Presenter: Ariel Finkelstein June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Periprocedural Transaortic Valve LVOT Migration With Successful Reposition: "The Double-Snare Technique Presenter: Howard C. Herrmann, Fabian Nietlispach, Matja Bunc, MD June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Instructive Case Examples: A Tale of Three Bicuspids To Treat or Not to Treat? Presenter: John C Laschinger, Mathew Williams, Hasan Jilaihawi June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Techniques to Reduce the Frequency of Pacemaker Implantation After TAVR Presenter: Hemal Gada June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Hybrid Beating Coronary Artery Bypass Grafting and Transcatheter Aortic Valve Replacement via Right Carotid Artery Access in a Patient With Severe Peripheral Arterial Disease Presenter: Howard C. Herrmann, Fabian Nietlispach, Marc Gerdisch, MD June 21, 2018